A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

NCT01153815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebrovascular Accident

Interventions

DRUG: GSK1358820(Botulinum toxin type A)
DRUG: placebo

Sponsor

GlaxoSmithKline